Enlarge / The director of Germany’s National Reference Centre for Invasive Fungal Infections holds a petri dish containing the yeast Candida auris in a laboratory at Wuerzburg University. Getty | Nicolas Armer
A deadly, drug-resistant fungus emerging in the US gained ground faster and picked up yet more drug resistance amid the COVID-19 pandemic, researchers at the Centers for Disease Control and Prevention reported Monday.
The yeast Candida auris has been considered an “urgent threat”—the CDC’s highest level of concern—since it was first reported in the US in 2016. The yeast lurks in health care settings and preys upon vulnerable
→ Continue reading at Ars Technica